#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13562	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2458	664.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1712	1712	T	856	T,C	855,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13562	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2458	664.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	873	C,T	872,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4030	714.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1874	1874	A	892	A,C	890,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4030	714.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2508	2508	C	768	C,T	767,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4030	714.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2582	2582	A	752	A,C	751,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4030	714.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3134	3134	C	815	C,A	814,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	G5V	NONSYN	13	15	GGT	484	486	GTT	139;138;138	G;T;T,C	139;138;137,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	E12K	NONSYN	34	36	GAA	505	507	AAA	149;151;153	A;A,C;A	149;150,1;153	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	F31L	NONSYN	91	93	TTT	562	564	TTG	163;163;162	T;T;G,T	163;163;161,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	595	597	CAA	172;173;175	C;A,G;A	172;172,1;175	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	S75P	NONSYN	223	225	TCC	694	696	CCT	165;168;165	C;C,A;T,G	165;167,1;164,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	V87A	NONSYN	259	261	GTA	730	732	GCA	142;141;142	G;C;A	142;141;142	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	V130L	NONSYN	388	390	GTC	859	861	CTC	201;202;202	C;T,G;C	201;201,1;202	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	R135C	NONSYN	403	405	CGC	874	876	TGT	196;197;193	T;G;T	196;197;193	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	T137A	NONSYN	409	411	ACG	880	882	GCG	188;189;185	G;C;G	188;189;185	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	922	924	AAG	187;187;187	A;A,C;G	187;185,2;187	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	T152N	NONSYN	454	456	ACC	925	927	AAT	190;193;196	A;A;T	190;193;196	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1123	1125	TTG	154;153;150	T;T;G	154;153;150	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1153	1155	AGC	127;124;122	A;G;C	127;124;122	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1222	1224	CTG	94;92;95	C;T;G	94;92;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1228	1230	TCC	91;91;92	T;C;C	91;91;92	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1243	1245	GTG	95;98;97	G;T;G	95;98;97	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1542	folP	852	852	93.78	folP.l15.c4.ctg.1	1948	98.6	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1294	1296	GCG	142;142;141	G;C;G	142;142;141	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3919	158.7	1	SNP	p	S91F	0	.	.	271	273	TCC	833	835	TCC	197;196;197	T;C;C	197;196;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3919	158.7	1	SNP	p	D95N	0	.	.	283	285	GAC	845	847	GAC	208;207;208	G;A,G;C	208;206,1;208	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3919	158.7	1	SNP	p	D95G	0	.	.	283	285	GAC	845	847	GAC	208;207;208	G;A,G;C	208;206,1;208	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1934	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1880	128.3	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	1040	1040	T	214	T	214	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1060	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1461	89.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1769	1771	ATC	222;224;226	A;T;C,T	222;224;225,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1922	1924	GCA	212;212;214	G;C;A	212;212;214	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	1	SNP	p	D86N	0	.	.	256	258	GAC	875	877	GAC	194;192;192	G;A,G,C;C	194;190,1,1;192	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	1	SNP	p	S87R	0	.	.	259	261	AGT	878	880	AGT	190;191;190	A,C;G;T,G	189,1;191;189,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	1	SNP	p	S87W	0	.	.	259	261	AGT	878	880	AGT	190;191;190	A,C;G;T,G	189,1;191;189,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	1	SNP	p	S87I	0	.	.	259	261	AGT	878	880	AGT	190;191;190	A,C;G;T,G	189,1;191;189,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4512	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3601	156.5	1	SNP	p	S88P	0	.	.	262	264	TCC	881	883	TCC	192;190;192	T;C,T;C	192;189,1;192	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3890	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3227	150.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1869	1871	GGC	211;209;209	G;G;C	211;209;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1525	1527	GCA	195;197;196	G;C;A	195;197;196	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1528	1530	ATC	194;188;188	A;T;C	194;188;188	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1540	1542	GTG	184;187;185	G,T;T;G	183,1;187;185	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1540	1542	GTG	184;187;185	G,T;T;G	183,1;187;185	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2044	2046	ACC	215;215;216	A;C;C	215;215;216	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2098	2100	GCG	206;205;204	G;C,A;G	206;204,1;204	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2098	2100	GCG	206;205;204	G;C,A;G	206;204,1;204	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2221	2223	GGT	211;208;207	G,C;G;T	210,1;208;207	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2230	2232	GGC	202;199;202	G;G;C	202;199;202	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3810	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2863	165.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2248	2250	CCG	203;206;205	C;C;G	203;206;205	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5222	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3763	173.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2248	porA	1146	1146	99.74	porA.l15.c17.ctg.1	2329	120.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	688	690	GGC	157;155;157	G;G;C	157;155;157	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2248	porA	1146	1146	99.74	porA.l15.c17.ctg.1	2329	120.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	870	870	C	174	C	174	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	44.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	19;20;22	T;T;A	19;20;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	44.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	55;55;55	C;A;T	55;55;55	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	44.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	55;55;55	A;G;T	55;55;55	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	270	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	44.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	55;55;55	T;A;C	55;55;55	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2810	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1613	207.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1064	1064	T	227	T	227	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2810	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1613	207.2	1	SNP	p	G120K	0	.	.	358	360	GGT	791	793	GGT	252;252;253	G,A;G;T	251,1;252;253	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2810	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1613	207.2	1	SNP	p	A121D	0	.	.	361	363	GCC	794	796	GCC	251;250;251	G;C;C,A	251;250;250,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2810	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1613	207.2	1	SNP	p	A121N	0	.	.	361	363	GCC	794	796	GCC	251;250;251	G;C;C,A	251;250;250,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9286	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5391	215.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2279	2281	CAT	231;235;238	C;A;T,G	231;235;237,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1358	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1603	105.6	1	SNP	p	V57M	1	.	.	169	171	ATG	757	759	ATG	232;232;232	A;T;G	232;232;232	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
